Journal
CANCER RESEARCH
Volume 73, Issue 5, Pages 1570-1580Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-12-2350
Keywords
-
Categories
Funding
- Academy of Finland
- Sigrid Juselius Foundation
- Finnish Cancer Foundations
- Biocentrum Helsinki
- ERA-NET SysBio+ (Synergy)
- Helsinki University Central Hospital
- European Union [LSHM-CT-2005-018652]
- Finnish Cultural Foundation
- GPBM
- HBGP
- FICS Graduate Programs
Ask authors/readers for more resources
The forkhead protein FoxA1 has functions other than a pioneer factor, in that its depletion brings about a significant redistribution in the androgen receptor (AR) and glucocorticoid receptor (GR) cistromes. In this study, we found a novel function for FoxA1 in defining the cell-type specificity of AR- and GR-binding events in a distinct fashion, namely, for AR in LNCaP-1F5 cells and for GR in VCaP cells. We also found different, cell-type and receptor-specific compilations of cis-elements enriched adjacent to the AR-and GR-binding sites. The AR pathway is central in prostate cancer biology, but the role of GR is poorly known. We find that AR and GR cistromes and transcription programs exhibit significant overlap, and GR regulates a large number of genes considered to be AR pathway-specific. This raises questions about the role of GR in maintaining the AR pathway under androgen-deprived conditions in castration-resistant prostate cancer patients. However, in the presence of androgen, ligand-occupied GR acts as a partial antiandrogen and attenuates the AR-dependent transcription program. Cancer Res; 73(5); 1570-80. (C) 2012 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available